top of page
bnl_symbol.png

Biophotonics and Nanomedicine Laboratory

research_nano_black_1.png

Mission.

Development of technologies that can practically be used in a variety of medical applications, such as treatment and diagnosis, with nano-sized optical materials  and drug carriers 

is the ultimate goal of BNL

The process begins with the synthesis and fundamental study of nanomaterials, continues with animal and cell experiments, and culminates in clinical trials.

For our research to become a valuable medical tool, we collaborate with BioACTs, DR.Nano,

Seoul National University Hospital, and other leading institutions.

box_reflect.png

Biophotonics.

Biophotonics denotes a combination of biology and photonics, being the science and technology of generation, manipulation, and detection of photons in biological systems.

biophotonics_1.png
box_reflect.png

Nanomedicine.

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials and biological devices to nanoelectronic biosensors.

nanomedicine_1.png

BIOPHOTONICS

In vitro sensor

Along with the fast population aging, the number of patients with age-related degenerative diseases is also increasing. Therefore, highly selective treatment options and susceptible diagnostic technologies are needed. Our group is developing luminescence-based particles with high sensitivity to detect disease-related makers in the blood, in order to overcome the difficulties associated with conventional blood-based diagnostics.

research_1.png

In vitro diagnostic techniques from blood

We synthesize particles that selectively respond to disease-related factors in the blood, and detect different reactive chemical species that affect the cells while minimizing interference with other blood components like proteins.

research_2.png

Luminescence-based techniques

We detect target factors in the blood at low concentrations by electrochemiluminescence, chemiluminescence, fluorescence, and other luminescence phenomena.

활성화학종 이미지_Homepage.png

Ultimately, we are developing a diagnostic platform that can monitor multiple diseases simultaneously.

ROS (Reactive Oxygen Species) 

RNS (Reactive Nitrogen Species) 

RSS (Reactive Sulfur Species) 

research_cube_guide.png

Reactive chemical species detection for multiple/simultaneous point-of-care testing(POCT) platforms

Molecular imaging

Molecular imaging is a technology that visualizes changes at the molecular level in vivo in real time and is applied to various fields such as drug delivery and disease monitoring. We develop diagnostic technologies based on chemiluminescence and fluorescence for clear and selective in vivo imaging.

Conventional strategy

Bioimaging_1-5_1_1.png
Bioimaging_1-1.png
Bioimaging_1-1.png
Bioimaging_1-1.png
Bioimaging_1-1.png

BNL’s  strategy

Bioimaging_1-2.png
Bioimaging_1-5_2_1.png

In conventional diagnostic systems, light irradiation for excitation and imaging by fluorescence which emits light in a short lifetime must be performed simultaneously. However, In our research, we synthesize new materials for imaging that have high sensitivity and selectivity for diseases that minimize autofluorescence by afterglow methods.

NANOMEDICINE

Nanomedicine is a branch of medicine that focuses on the medical application of nanotechnology to overcome the limitations of existing drugs and to improve the stability and effectiveness of treatments by adjusting the delivery and activity of medications in accordance with disease characteristics. Using nanoparticle formulations, we are developing treatments for various cancers, Alzheimer's disease, and aging diseases.

Gene therapy

Gene therapy can restore disease phenotypes to normal by inhibiting abnormal gene expression or replacing abnormal genes with normal ones. We study ways to deliver unstable nucleic acid-based drugs to the target site in vivo using nanoparticles while protecting the nucleic acids from degradation to enhance their efficacy.

Nanomedicine_more1_1.png

siRNA

Nanocarrier

Stabilizer

Gene delivery Nanoparticle

Phototherapy (PDT/PTT)

Phototherapy uses light-sensitive agents that absorb light at a specific wavelength and is applied to bioimaging, therapy, and diagnosis. Typically, photodynamic therapy (PDT) involves the use of reactive oxygen species generated by photosensitive agents to remove cells. Our research focuses on the selective delivery of photosensitive agents to disease sites using nanoparticles. We also research photothermal therapy (PTT).

phototheraphy_3.png

Surfactant

Stabilizer

Photosensitizer

PDT Nanoparticle

photo_theraphy_1.jpg

Immunotherapy

Untitled.png

Immunotherapy is a next-generation treatment that utilizes the immune system in terms of excellent therapeutic effects and stability. Through adjuvants and damage-associated molecular pattern (DAMP) signal secretion, nanoparticles can amplify signals at disease sites and alert immune cells to abnormal cells.

KIST_logo_w.png
KUkist로고_w.png
UST_logo_w.png
bnl_symbol.png

Add   L1103, 5 Hwarang-ro 14-gil, Wolgok 2(i)-dong, Seongbuk-gu, Seoul

Tel    02-958-5919

© 2022 by KIST BNL. Proudly created with Y-KNOTS Cooperation

bottom of page